Viemed Healthcare, Inc.

NASDAQ:VMD

Medical - Devices

Healthcare
$8.78 +0.68%

+$0.07 today

Market cap
$332.70M
Beta
1.13
P/E (TTM)
27.4
EPS (TTM)
$0.39
52W Low $5.93High $10.68

Volume 0.26M

Average 0.26M

VMD Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Viemed Healthcare, Inc.NASDAQ: VMD

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income dips below year-ago levels

Q1 FY2026 net income of $2.58M fell 4.7% year over year, behind the +21.1% change in trailing-twelve-month net income. Sequentially, it fell 55.6% from the prior quarter. Over 3 fiscal years it compounded at +33.9% a year.

Context

  • Net income amounted to 5.5% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Net income increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 3 analysts of $16.13M (+8.0%) for the fiscal year ending Dec 2026, a slowdown from the +30.9% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.58M-55.6% QoQ
Last fiscal yearDec 2025
$14.93M+30.9% YoY
LTMMar 2026
$15.16M+21.1% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.7%+56.6%+61.3 pp
1 year+30.9%+8.0%-22.9 pp
3-year CAGR+33.9%+18.3%-15.6 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
14.93M USD
Year-over-year change
+30.9%
4-year CAGR
+13.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How VMD compares with its peers on the latest reported figures

  • VMD's LTM Mar 2026 net income of $15.16M is the 9th largest of the 11 companies compared; the peer median is $44.96M.
  • Its year-over-year change of +21.1% is the 6th highest of 11, against a peer median of +29.0%.
  • Net income amounts to 5.3% of revenue for VMD, versus a peer median of 62.6%.
VMD Competitors Peer median
Net Income for VMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QTRXQuanterix CorporationLTM Mar 2026$104.19M +117.6%+3.5%71.9%
SENSSenseonics Holdings, Inc.LTM Mar 2026$87.19M +17.8%—214.2%
NNOXNano-X Imaging Ltd.LTM Dec 2025$75.02M +40.2%-10.7%576.1%
OMOutset Medical, Inc.LTM Mar 2026$74.85M -34.2%-20.6%63.7%
CVRXCVRx, Inc.LTM Mar 2026$52.66M +2.2%+8.8%89.1%
SGHTSight Sciences, Inc.LTM Mar 2026$37.25M -24.6%-23.6%46.8%
MASS908 Devices Inc.LTM Mar 2026$35.6M +101.3%—61.6%
INGNInogen, Inc.LTM Mar 2026$24.9M -9.4%-35.2%7.1%
VMDViemed Healthcare, Inc.LTM Mar 2026$15.16M +21.1%+33.9%5.3%
ELMDElectromed, Inc.LTM Mar 2026$10.1M +41.1%+48.4%14.1%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$4.24M +113.0%—9.6%
Peer median (excluding VMD) $44.96M+29.0%-10.7%62.6%

Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income9.13M6.22M10.24M11.41M14.93M
Depreciation & Amortization11.31M15.63M21.86M25.37M28.61M
Deferred Income Tax3.88M1.75M(1.44M)(3.84M)3.11M
Stock-Based Compensation5.15M5.2M5.85M6.29M9.13M
Change in Working Capital(13.56M)(10.14M)7.78M355K(2.3M)
Accounts Receivables(7.35M)(12.57M)(1.08M)(6.07M)1.16M
Inventory(212K)301K(480.66K)574K59K
Accounts Payables133K(318K)(874.75K)359K479K
Other Working Capital(6.14M)2.45M10.21M5.5M(4M)
Other Non-Cash Items6.58M9.08M921K(488K)(1.57M)
Operating Cash Flow22.49M27.75M45.21M39.09M51.92M
Capital Expenditures(19.74M)(22.9M)(26.09M)(37.77M)(39.99M)
Acquisitions (Net)(599K)(141K)(28.59M)(3M)(26.33M)
Purchases of Investments(593.73K)(2M)000
Sales of Investments593.73K00750K0
Other Investing Activities596K1.06M2.57M9.32M16.15M
Investing Cash Flow(19.75M)(23.98M)(52.11M)(30.7M)(50.17M)
Debt Repayment(4M)(5.84M)2.12M(3.41M)8.15M
Common Stock Issued00001.44M
Common Stock Repurchased(1.43M)(9.71M)(594K)(1.07M)(13.23M)
Dividends Paid00000
Other Financing Activities112K283K1.3M789K(2.16M)
Financing Cash Flow(5.32M)(15.27M)2.83M(3.69M)(5.79M)
Effect of Forex Changes00000
Net Change in Cash(2.57M)(11.49M)(4.08M)4.7M(4.04M)
Free Cash Flow2.75M4.85M19.12M1.32M11.93M

Viemed Healthcare, Inc.

NASDAQ:VMD

Intrinsic Alpha fair value

Locked

Current Price

$8.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.